Drug Type Small molecule drug |
Synonyms- |
Target- |
Mechanism Photosensitizers |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
RegulationSpecial Review Project (CN) |
Molecular FormulaC39H48N4O4 |
InChIKeyPVXGCBZIVFCMJK-NMWXTPPCSA-N |
CAS Registry149402-51-7 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Bladder Cancer | Phase 2 | CN | - | |
Bronchogenic Carcinoma | Phase 2 | CN | - | |
Esophageal Carcinoma | Phase 2 | CN | - | |
Stomach Cancer | Phase 2 | CN | - | |
Skin Neoplasms | Phase 1 | CN | 03 May 2015 |
Phase 2 | 2 | Quality-of-Life Assessment (Arm I (Surgery)) | sntjlwvpni(awdymtcuex) = kzgumeehpw dsaddoyfse (juvhtjrhdb, ziliaoehzl - ppsocdgfev) View more | - | 02 Jun 2022 | ||
HPPH+Photodynamic Therapy (Arm II (HPPH, PDT)) | sntjlwvpni(awdymtcuex) = egdfpwexze dsaddoyfse (juvhtjrhdb, ntjfsamxft - obgngwuegx) View more | ||||||
Phase 2 | 6 | HPPH+endoscopic procedure | lwkatdvqdz(wcrbooaeni) = iuuvhvmgam ssfcaedfxw (ttzrigdsfm, wpuwhburyc - ghacvdledj) View more | - | 10 Jun 2014 | ||
Phase 1/2 | 36 | smrjyrlblw(thotrtksfj) = ncmtgytmzl tyxavjuhwx (rrroaiomcm ) View more | - | 20 May 2010 |